Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Dong, NJ

Guizhen Dong, Dayton, NJ US

Patent application numberDescriptionPublished
201100711302-AMINOBENZIMIDAZOLES FOR TREATING NEURODEGENERATIVE DISEASES - The invention relates to 2-aminobenzimidazoles useful in treating disorders that are mediated by A03-24-2011

Patent applications by Guizhen Dong, Dayton, NJ US

Hong Dong, Livingston, NJ US

Patent application numberDescriptionPublished
20090105210Bicyclic Pyrimidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes - The present invention is directed to novel substituted bicyclic pyrimidines which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DPP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.04-23-2009
20100056550TRICYCLIC HETEROAROMATIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES - The present invention is directed to novel substituted tricyclic heteroaromatic compounds of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.03-04-2010

Patent applications by Hong Dong, Livingston, NJ US

Jerry Dong, Oakland, NJ US

Patent application numberDescriptionPublished
20110288628COMPOSITE PROSTHESIS WITH EXTERNAL POLYMERIC SUPPORT STRUCTURE AND METHODS OF MANUFACTURING THE SAME - A prosthesis including a support structure for enhancing kink and/or crush resistance. The support structure is connected to an outer surface of the prosthesis and includes at least two components, one of which has a lower melting point than the other. The component with the lower melting point is used to connect the support structure to the outer surface of the prosthesis.11-24-2011

Li Dong, Lawrenceville, NJ US

Patent application numberDescriptionPublished
20090306100METHODS OF TREATING SCHIZOPHRENIA - This invention relates to methods for treating, managing and preventing cognitive impairment associated with various diseases and disorders, age-associated memory impairment, and dementia.12-10-2009
20100081691MULTICYCLIC COMPOUNDS AND METHODS OF THEIR USE - This invention relates to multicyclic compounds, pharmaceutical compositions comprising them, and methods of their use in, for example, the treatment of cognitive disorders.04-01-2010
20110251207BIARYL-SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA 2C ADRENERGIC RECEPTOR MODULATORS - In its many embodiments, the present invention provides a novel class of biaryi spiroaminooxazoline analogues as modulators of α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions.10-13-2011

Patent applications by Li Dong, Lawrenceville, NJ US

Li Dong, Roselle Park, NJ US

Patent application numberDescriptionPublished
20110245264Modulators of G Protein-Coupled Receptor 88 - The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled receptor 88.10-06-2011

Shuan Dong, Watchung, NJ US

Patent application numberDescriptionPublished
20100113821PREPARATION OF 3-AMINO-3-(CYCLOBUTYLMETHYL)-2-(HYDROXY)-PROPIONAMIDE HYDROCHLORIDE - Disclosed is a process for preparing 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamide hydrochloride, an intermediate useful in the preparation of the HCV protease inhibitor (1R,5S)—N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide.05-06-2010
20110034705Process For the Synthesis of 3- Amino-3-Cyclobuthylmethyl-2-Hydroxypropionamide or Salts Thereof - A process for preparing 3-amino-3-cyclobutylmethyl-2-hydroxypropionamide of the Formula I:02-10-2011

Victor Jun Dong, Edison, NJ US

Patent application numberDescriptionPublished
20090020606ELECTRONIC VOTING METHOD AND SYSTEM EMPLOYING A MACHINE READABLE BALLOT ENVELOPE - A method for reading a sheet or a paper ballot enclosed in a ballot envelope comprises decoding a machine readable envelope identifier from each ballot envelope, displaying at least the decoded envelope identifier and a signature from each ballot envelope for determining from the envelope identifier, the signature, or both, whether a valid sheet or ballot is presented. If the sheet or ballot is valid, then the sheet or ballot is removed from its envelope and the selections marked on the sheet or ballot may then be determined and processed.01-22-2009
20090289115OPTICALLY READABLE MARKING SHEET AND READING APPARATUS AND METHOD THEREFOR - A ballot or sheet having an anti-copying feature provides for detecting from an image of the ballot or sheet whether the ballot or sheet is an original or is a copy. The anti-copying feature may lighten or darken, or both, when copied and may or may not be evident to the human eye. A reader comprising an imager and a processor is for reading the ballot or sheet and for determining whether the ballot or sheet is an original or is a copy, and for determining selections marked thereon. A method for reading the ballot or sheet is for determining from an image of the ballot or sheet whether the ballot or sheet is an original or is a copy, and for determining selections marked thereon.11-26-2009
20100115634PHYSICALLY SECURE COMPUTING SYSTEM AND DEVICE, AND PHYSICALLY SECURE CONTAINER THEREFOR - A secured computing system and container therefor may comprise: a base for receiving a computing device; a securable first cover for substantially enclosing at least part of the computing device when the first cover is in a first position in the base; a securable second cover for preventing access to the computing device when the second cover is in a secured position, wherein access to the computing device is available when the second cover is not in the secured position. The computing device may be substantially enclosed when the first cover is in the first position in the base and the second cover is in the secured position; and one or more user features of the computing device may be accessible when the first cover is not in the first position in the base. The computing device may include a computer processor or computer peripheral.05-06-2010
20100170948METHOD FOR DECODING AN OPTICALLY READABLE SHEET - An optically readable sheet has plural mark spaces and has at least two fiducial marks defining the orientation and scaling of the sheet. A method for reading an optically readable sheet may comprise imaging the sheet and decoding the fiducial marks from the image of the sheet for scaling the image of the sheet and decoding the mark spaces therein. Scaling the image may include comparing the locations of the decoded fiducial marks from the image of the sheet and the predetermined locations of the fiducial marks on the sheet.07-08-2010

Patent applications by Victor Jun Dong, Edison, NJ US

Xiao Dong, Warren, NJ US

Patent application numberDescriptionPublished
20110224187PYRROLIDINE, PIPERIDINE AND PIPERAZINE DERIVATIVES AND METHODS OF USE THEREOF - The present invention relates to novel Pyrrolidine, Piperidine and Piperazine Derivatives, pharmaceutical compositions comprising the Pyrrolidine, Piperidine and Piperazine Derivatives and the use of these compounds for treating or preventing treating allergy, an allergy-induced airway response, congestion, a cardiovascular disease, an inflammatory disease, a gastrointestinal disorder, a neurological disorder, a metabolic disorder, obesity, an obesity-related disorder, diabetes, a diabetic complication, impaired glucose tolerance or impaired fasting glucose.09-15-2011

Xiaowei Dong, Parsippany, NJ US

Patent application numberDescriptionPublished
20110195030NANOPARTICLE COMPOSITIONS COMPRISING LIQUID OIL CORES - Nanocapsule and nanoemulsion particle compositions having improved physical and pharmacological properties are provided. The nanocapsule or nanoemulsion particle composition can comprise a pharmaceutically acceptable liquid oil phase, a surfactant, and optionally a co-surfactant. The liquid oil phase can comprise a monoglyceride, a diglyceride, a triglyceride, a propylene glycol ester, or a propylene glycol diester. In certain embodiments, the nanocapsule or nanoemulsion particle composition can be lyophilized and subsequently re-hydrated without increasing the mean particle size and/or adversely affecting the potency or efficacy of a therapeutic agent (e.g., paclitaxel) present in the nanocapsules or nanoemulsion particles.08-11-2011

Xin Dong, Morristown, NJ US

Patent application numberDescriptionPublished
20100293129DEPENDENCY BETWEEN SOURCES IN TRUTH DISCOVERY - A method and system for truth discovery may implement a methodology that accounts for accuracy of sources and dependency between sources. The methodology may be based on Bayesian probability calculus for determining which data object values published by sources are likely to be true. The method may be recursive with respect to dependency, accuracy, and actual truth discovery for a plurality of sources.11-18-2010

Zedong Dong, Princeton, NJ US

Patent application numberDescriptionPublished
20080293787PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS - The invention relates to solid dispersions of poorly soluble compounds formed by co-precipitation and hot melt extrusion, resulting in improved stability and bioavailability. The invention also relates to hot melt extrusion processes used to prepare such solid dispersions.11-27-2008
20110028524PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS - The invention relates to solid dispersions of poorly soluble compounds formed by co-precipitation and hot melt extrusion, resulting in improved stability and bioavailability. The invention also relates to hot melt extrusion processes used to prepare such solid dispersions.02-03-2011
20110245305PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS - The invention relates to solid dispersions of poorly soluble compounds formed by co-precipitation and hot melt extrusion, resulting in improved stability and bioavailability. The invention also relates to hot melt extrusion processes used to prepare such solid dispersions.10-06-2011

Ziqian Dong, Kearny, NJ US

Patent application numberDescriptionPublished
20090059921REPLICATING AND SWITCHING MULTICAST INTERNET PACKETS IN ROUTERS USING CROSSPOINT MEMORY SHARED BY OUTPUT PORTS - Multicast traffic is expected to increase in packet networks, and therefore in switches and routers, by including broadcast and multimedia-on-demand services. Combined input-crosspoint buffered (CICB) switches can provide high performance under uniform multicast traffic. However this is often at the expense of N03-05-2009
20100260198Space-Space-Memory (SSM) Clos-Network Packet Switch - A Clos-network packet switching system may include input modules coupled to a virtual output queue, central modules coupled to the input modules, and output modules coupled to the central modules, each output module having a plurality of cross-point buffers for storing a packet and one or more output ports for outputting the packet.10-14-2010
20110026532Forwarding Data Through a Three-Stage Clos-Network Packet Switch with Memory at each Stage - Examples are disclosed for forwarding data partitioned into one or more cells through at least a portion of a three-stage memory-memory-memory (MMM) input-queued Clos-network (IQC) packet switch. In some examples, each module of the three-stage MMM IQC packet switch includes a virtual queue and a manager that are configured in cooperation with one another to forward cells through at least a portion of the switch. The cells may have been partitioned and stored at an input port for the switch and destined for an output port for the switch.02-03-2011
20110026539Forwarding Cells of Partitioned Data Through a Three-Stage Clos-Network Packet Switch with Memory at Each Stage - Examples are disclosed for forwarding cells of partitioned data through a three-stage memory-memory-memory (MMM) input-queued Clos-network (IQC) packet switch. In some examples, each module of the three-stage MMM IQC packet switch includes a virtual queue and a manager that are configured in cooperation with one another to forward a cell from among cells of partitioned data through at least a portion of the switch. The cells of partitioned data may have been partitioned and stored at an input port for the switch and have a destination of an output port for the switch.02-03-2011

Patent applications by Ziqian Dong, Kearny, NJ US